[Pubmed] Letter to the editor: Steroid-sparing implications of efgartigimod in generalized myasthenia gravis
Posté : 27 sept. 2025 12:00
J Neurol Sci. 2025 Sep 22;478:123705. doi: 10.1016/j.jns.2025.123705. Online ahead of print.
NO ABSTRACT
PMID:41014942 | DOI:10.1016/j.jns.2025.123705
Source: https://pubmed.ncbi.nlm.nih.gov/4101494 ... t9+e462414